Health
Decrease in serum antibodies to SARS‐CoV‐2 in convalescent plasma donors over time – Wiley
Click on the article title to read more.
To the Editor
Convalescent plasma, collected from donors who have previously recovered from viral illnesses, has been used to treat patients with a variety of emerging infectious diseases. This product has become more prominent during the current COVID19 pandemic, including with the recent emergency use authorization from the Food and Drug Administration, but the longevity of SARSCoV2 antibodies in donated plasma is unknown. Historically, convalescent plasma has been used to reduce mortality in…
-
Noosa News21 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News22 hours agoForum responds to urgent homelessness issues in Nambour
-
Business19 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General24 hours agoFirst home buyers score early access to deposit scheme